Delving into the Latest Updates on Chaiqin Tonglin Tablets with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Infectious DiseasesUrogenital Diseases

Active Indication

Acute lower urinary tract infection

Inactive Indication-

Originator Organization

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Active Organization

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

（1）探索柴芩通淋片治疗反复发作尿路感染（肝经气机郁滞、湿热蕴结下焦证）的合理剂量；（2）初步评价柴芩通淋片治疗反复发作尿路感染（肝经气机郁滞、湿热蕴结下焦证）的有效性；（3）初步评价柴芩通淋片临床应用的安全性。

[Translation]

(1) To explore the reasonable dosage of Chaiqin Tonglin Tablets for the treatment of recurrent urinary tract infections (liver meridian qi stagnation, damp-heat accumulation in the lower jiao syndrome); (2) To preliminarily evaluate the effectiveness of Chaiqin Tonglin Tablets in the treatment of recurrent urinary tract infections (liver meridian qi stagnation, damp-heat accumulation in the lower jiao syndrome); (3) To preliminarily evaluate the safety of Chaiqin Tonglin Tablets in clinical application.

Start Date11 Jan 2024

Sponsor / Collaborator

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

ChiCTR2400087723

/ RecruitingPhase 2IIT

A multicenter, randomized, double-blind, dose exploration, placebo parallel controlled phase II clinical study on Chaiqin Tonglin tablets for the treatment of recurrent urinary tract infections (liver meridian qi stagnation, damp heat accumulation and lower jiao syndrome) - Evaluation of the safety, efficacy, and optimal dosage of Chaiqin Tonglin tablets in the treatment of recurrent urinary tract infections

Start Date11 Jan 2024

Sponsor / Collaborator